These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26590166)

  • 1. Hemolysate-mediated platelet aggregation: an additional risk mechanism contributing to thrombosis of continuous flow ventricular assist devices.
    Tran PL; Pietropaolo MG; Valerio L; Brengle W; Wong RK; Kazui T; Khalpey ZI; Redaelli A; Sheriff J; Bluestein D; Slepian MJ
    Perfusion; 2016 Jul; 31(5):401-8. PubMed ID: 26590166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin has limited ability to modulate shear-mediated platelet activation associated with elevated shear stress of ventricular assist devices.
    Valerio L; Tran PL; Sheriff J; Brengle W; Ghosh R; Chiu WC; Redaelli A; Fiore GB; Pappalardo F; Bluestein D; Slepian MJ
    Thromb Res; 2016 Apr; 140():110-117. PubMed ID: 26938158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shear-mediated platelet activation in patients implanted with continuous flow LVADs: A preliminary study utilizing the platelet activity state (PAS) assay.
    Valerio L; Consolo F; Bluestein D; Tran P; Slepian M; Redaelli A; Pappalardo F
    Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():1255-8. PubMed ID: 26736495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of LDH isoenzymes in hemolysis and continuous-flow left ventricular assist device-induced thrombosis.
    Gordon JS; Wood CT; Luc JGY; Watson RA; Maynes EJ; Choi JH; Morris RJ; Massey HT; Throckmorton AL; Tchantchaleishvili V
    Artif Organs; 2020 Mar; 44(3):231-238. PubMed ID: 31494952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.
    Gavalas MV; Breskin A; Yuzefpolskaya M; Eisenberger A; Castagna F; Demmer RT; Flannery M; Garan AR; Takeda K; Takayama H; Naka Y; Topkara VK; Colombo PC
    J Heart Lung Transplant; 2017 Jan; 36(1):59-63. PubMed ID: 27773451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients.
    Whitson BA; Eckman P; Kamdar F; Lacey A; Shumway SJ; Liao KK; John R
    Ann Thorac Surg; 2014 Jun; 97(6):2097-103. PubMed ID: 24775803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis.
    Bartoli CR; Zhang D; Kang J; Hennessy-Strahs S; Restle D; Howard J; Redline G; Bermudez C; Atluri P; Acker MA
    Ann Thorac Surg; 2018 Mar; 105(3):807-814. PubMed ID: 28942075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices.
    Bitar A; Vijayakrishnan R; Lenneman A; Birks E; Massey T; Slaughter M; Abramov D
    Artif Organs; 2017 Dec; 41(12):1092-1098. PubMed ID: 28621461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil Is Associated With Reduced Device Thrombosis and Ischemic Stroke Despite Low-Level Hemolysis on Heart Mate II Support.
    Saeed O; Rangasamy S; Selevany I; Madan S; Fertel J; Eisenberg R; Aljoudi M; Patel SR; Shin J; Sims DB; Reyes Gil M; Goldstein DJ; Slepian MJ; Billett HH; Jorde UP
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29092891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
    Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
    Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
    J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pump Thrombosis following HeartMate II Left Ventricular Assist Device Implantation in a Patient with Aspirin and Plavix Resistance.
    Ghodsizad A; Badiye A; Zeriouh M; Pae W; Koerner MM; Loebe M
    Heart Surg Forum; 2016 Dec; 19(6):E284-E285. PubMed ID: 28054898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood damage in Left Ventricular Assist Devices: Pump thrombosis or system thrombosis?
    Selmi M; Chiu WC; Chivukula VK; Melisurgo G; Beckman JA; Mahr C; Aliseda A; Votta E; Redaelli A; Slepian MJ; Bluestein D; Pappalardo F; Consolo F
    Int J Artif Organs; 2019 Mar; 42(3):113-124. PubMed ID: 30354870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro comparison of blood pump induced platelet microaggregates between a centrifugal and roller pump during cardiopulmonary bypass.
    Linneweber J; Chow TW; Kawamura M; Moake JL; Nosè Y
    Int J Artif Organs; 2002 Jun; 25(6):549-55. PubMed ID: 12117295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.
    Muthiah K; Robson D; Macdonald PS; Keogh AM; Kotlyar E; Granger E; Dhital K; Spratt P; Jansz P; Hayward CS
    Artif Organs; 2013 Mar; 37(3):313-8. PubMed ID: 23373528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment of Pediatric Ventricular Assist Device Thrombosis.
    Chetan D; Buchholz H; Bauman M; Anand V; Holinski P; Conway J
    ASAIO J; 2018; 64(2):e28-e32. PubMed ID: 28604570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argatroban as novel therapy for suspected thrombosis in patients with continuous-flow left ventricle assist device and hemolysis.
    Badiye A; Hernandez GA; Chaparro S
    ASAIO J; 2014; 60(3):361-5. PubMed ID: 24614354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early intervention for lactate dehydrogenase elevation improves clinical outcomes in patients with the HeartMate II left ventricular assist device: Insights from the PREVENT study.
    Thenappan T; Stulak JM; Agarwal R; Maltais S; Shah P; Eckman P; Emani S; Katz JN; Gregoric I; Keebler ME; Uriel N; Adler E; Chuang J; Farrar DJ; Sundareswaran KS; John R
    J Heart Lung Transplant; 2018 Jan; 37(1):25-32. PubMed ID: 29153636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.